{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:09:29Z","timestamp":1793390969399,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Orthop Relat Res"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Biomarkers of infection are measurable indicators that reflect the presence of an infection in the body. They are particularly valuable for detecting infections and tracking treatment responses. Previous transcriptome analysis of peripheral blood mononuclear cells (PBMCs) collected from patients during the active phase of diabetic foot infection identified the upregulation of several genes, including a neutrophil-specific cell surface glycoprotein, CD177, an Myb-related transcription factor 2 (MYBL2), and ribonucleotide reductase regulatory subunit M2 (RRM2). We aimed to investigate whether these observations in diabetic foot infections could be extrapolated to other musculoskeletal infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Questions\/purposes<\/jats:title>\n            <jats:p>(1) Are the protein concentrations of CD177, MYBL2, and RRM2 elevated in serum or PBMCs of patients with musculoskeletal infections? (2) Do serum and PBMC concentrations of CD177, MYBL2, and RRM2 decrease in response to antibiotic therapy? (3) Can these biomarkers give diagnostic accuracy and differentiate patients with musculoskeletal infections from controls?<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From April 2023 to June 2024, we treated 26 patients presenting with clinical symptoms and signs of acute musculoskeletal infections, including elevated inflammatory markers (white blood cell [WBC] and C-reactive protein [CRP]) and local changes such as swelling, erythema, tenderness or pain, warmth, purulent drainage, sinus tract, or wound leading to bone or hardware. Diagnosis included periprosthetic joint infection (PJI), foot and ankle infection (FAI), fracture-related infection (FRI), and septic arthritis of the native joints. Patients with chronic recurrent osteomyelitis, PJI, or FRI were excluded from the study. Among the 26 patients deemed potentially eligible, 19% (5) were excluded for the following reasons: prison inmate (1), unable to provide consent because of severe sepsis (1), mental illness (1), and declined to participate (2). Of the 81% (21) of patients who provided consent, cultures from 9.5% (2) were negative. These two patients were ultimately diagnosed with inflammatory arthritis: gout (1) and rheumatoid arthritis (1); thus, the musculoskeletal infection group for analysis consisted of 73.1% (19 of 26) of patients. A control group of 21 patients undergoing elective foot or ankle deformity correction surgery without infections or systemic inflammation was included. Because foot or ankle deformity is highly unlikely to influence the immunologic profile of the subjects, we believed that these patients would serve as an appropriate control group. Other than the absence of infection and the lower prevalence of diabetes mellitus, the control group was comparable to the study group in terms of demographics and clinical factors, including age and sex distribution. We collected blood samples from both patients and controls and quantified CD177, MYBL2, and RRM2 RNA transcription levels in the PBMC using qRT-PCR. We also assessed protein concentrations in the serum and PBMC using an enzyme-linked immunosorbent assay. A comparative analysis of the three biomarkers was performed on 19 patients with musculoskeletal infections with positive cultures and 21 controls to assess their diagnostic potential using the unpaired nonparametric t-test with the Mann-Whitney test. We obtained 8-week follow-up blood samples from seven patients with musculoskeletal infections who clinically healed. Healing was defined by normalization of inflammatory markers (WBC and CRP) and absence of swelling, erythema, local tenderness or pain, warmth, purulent drainage, sinus tract, or open wound. We performed a comparative analysis of the seven patients during active infection and after treatment to determine a change in the level of CD177, MYBL2, and RRM2 in their serum and PBMCs. These findings were also compared with those of the control group. We evaluated the diagnostic accuracy of CD177, MYBL2, and RRM2 for musculoskeletal infections using receiver operating characteristic (ROC) curve analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The musculoskeletal infections group showed a larger increased serum and PBMC concentrations of CD177, MYBL2, and RRM2 proteins compared with the control group. The mean protein concentrations of CD177, MYBL2, and RRM2 were increased in the serum and PBMC of the musculoskeletal infections group compared with the controls. Serum levels of all biomarkers investigated were higher in musculoskeletal infections group compared with the control group (CD177 227 [155 to 432] versus 54 [10 to 100], difference of medians 173, p &lt; 0.01; MYBL2 255 [231 to 314] versus 180 [148 to 214], difference of medians 75, p &lt; 0.01; RRM2 250 [216 to 305] versus 190 [148 to 255], difference of medians 60, p &lt; 0.01). Similarly, PBMC levels of all biomarkers were higher in the musculoskeletal infections group (CD177 55.3 [39.1 to 80.5] versus 17.5 [10.5 to 27.5], difference of medians 37.8, p &lt; 0.01; MYBL2 144 [114 to 190] versus 91 [70 to 105], difference of medians 53, p &lt; 0.01; RRM2 168 [143 to 202] versus 100 [77.5 to 133], difference of medians 68, p &lt; 0.01). Additionally, serum levels of all biomarkers decreased in seven patients with musculoskeletal infections after infection treatment (CD177 3080 [2690 to 3320] versus 4250 [3100 to 8640], difference of medians 1170, p &lt; 0.01; MYBL2 4340 [4120 to 4750] versus 5010 [4460 to 5880], difference of medians 670, p &lt; 0.01; RRM2 4350 [3980 to 5000] versus 5025 [4430 to 6280], difference of medians 675, p = 0.01). Similarly, PBMC levels of all biomarkers were lower after infection treatment (CD177 805 [680 to 980] versus 1025 [750 to 1610], difference of medians 220, p &lt; 0.01; MYBL2 2300 [2100 to 2550] versus 2680 [2220 to 3400], difference of medians 380, p = 0.02; RRM2 2720 [2500 to 3200] versus 3350 [2825 to 4030], difference of medians 630, p &lt; 0.01). The area under the ROC curve for diagnosing musculoskeletal infections in the serum and PBMC was as follows: <jats:italic toggle=\"yes\">CD177<\/jats:italic> 95% confidence interval [CI] &gt; 0.99 and &gt; 0.99, <jats:italic toggle=\"yes\">MYBL2 <\/jats:italic>95% CI &gt; 0.99 and &gt; 0.99, and<jats:italic toggle=\"yes\"> RRM2<\/jats:italic> 95% CI = 0.96 and &gt; 0.99, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We may utilize blood-based tests for CD177, MYBL2, and RRM2 to aid in the diagnosis of musculoskeletal infections, particularly when arthrocentesis or obtaining tissue culture is challenging. They may also assist in monitoring treatment response. As some of these biomarkers may also be elevated in other inflammatory conditions, a large-scale clinical study is needed to confirm their reliability in differentiating musculoskeletal infections from other inflammatory conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical Relevance<\/jats:title>\n            <jats:p>CD177, MYBL2, and RRM2 proteins in blood samples may serve as novel biomarkers for diagnosing and monitoring treatment response in musculoskeletal infections.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/corr.0000000000003402","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T03:00:07Z","timestamp":1738897207000},"page":"1062-1071","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["CD177, MYBL2, and RRM2 Are Potential Biomarkers for Musculoskeletal Infections"],"prefix":"10.1097","volume":"483","author":[{"given":"Taiwo Samuel","family":"Agidigbi","sequence":"first","affiliation":[{"name":"Department of Orthopedics and Rehabilitation, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-3008","authenticated-orcid":false,"given":"Brianna","family":"Fram","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Rehabilitation, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilda","family":"Molloy","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Rehabilitation, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6640-7071","authenticated-orcid":false,"given":"Matthew","family":"Riedel","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Rehabilitation, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wiznia","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Rehabilitation, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-5849","authenticated-orcid":false,"given":"Irvin","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Rehabilitation, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"1198115","DOI":"10.3389\/fcimb.2023.1198115","article-title":"Transcriptomic identification of genes expressed in invasive S. aureus diabetic foot ulcer infection","volume":"13","author":"Agidigbi","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1182\/blood-2017-03-768507","article-title":"CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation","volume":"130","author":"Bai","year":"2017","journal-title":"Blood"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40249-024-01249-6","article-title":"Global burden associated with rare infectious diseases of poverty in 2021: findings from the Global Burden of Disease Study 2021","volume":"13","author":"Bao","year":"2024","journal-title":"Infect Dis Poverty"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2013.06.013","article-title":"A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection","volume":"154","author":"Brandes","year":"2013","journal-title":"Cell."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1080\/15384101.2021.1982494","article-title":"Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene","volume":"20","author":"Chen","year":"2021","journal-title":"Cell Cycle"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.imlet.2016.08.011","article-title":"Identification of CD177 as the most dysregulated parameter in a microarray study of purified neutrophils from septic shock patients","volume":"178","author":"Demaret","year":"2016","journal-title":"Immunol Lett"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2020.05.006","article-title":"The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: a retrospective study in Suzhou China","volume":"192","author":"Fu","year":"2020","journal-title":"Thromb Res"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2106\/JBJS.16.01522","article-title":"The accuracy of the alpha defensin lateral flow device for diagnosis of periprosthetic joint infection: comparison with a gold standard","volume":"100","author":"Gehrke","year":"2018","journal-title":"J Bone Joint Surg Am."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00011-023-01849-2","article-title":"Identification of RRM2 as a key ferroptosis-related gene in sepsis","volume":"73","author":"He","year":"2024","journal-title":"Inflamm Res"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"780900","DOI":"10.3389\/fimmu.2021.780900","article-title":"Pulmonary mesenchymal stem cells in mild cases of COVID-19 are dedicated to proliferation; in severe cases, they control inflammation, make cell dispersion, and tissue regeneration","volume":"12","author":"Henriques-Pons","year":"2021","journal-title":"Front Immunol"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12969-019-0348-z","article-title":"Association between maternal age and outcomes in Kawasaki disease patients","volume":"17","author":"Huang","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"8509127","DOI":"10.1155\/2018\/8509127","article-title":"Biomarkers in infectious diseases","volume":"2018","author":"Hwang","year":"2018","journal-title":"Dis Markers"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1007\/s00018-015-1934-y","article-title":"Whole transcriptome analysis with sequencing: methods, challenges and potential solutions","volume":"72","author":"Jiang","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"901848","DOI":"10.3389\/fmicb.2022.901848","article-title":"Identification of novel therapeutic candidates against SARS-CoV-2 infections: an application of RNA sequencing toward mRNA based nanotherapeutics","volume":"13","author":"Khalid","year":"2022","journal-title":"Front Microbiol"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3904\/kjim.2013.28.3.285","article-title":"Procalcitonin as a biomarker of infectious diseases","volume":"28","author":"Lee","year":"2013","journal-title":"Korean J Intern Med"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"102711","DOI":"10.1016\/j.isci.2021.102711","article-title":"CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death","volume":"24","author":"Levy","year":"2021","journal-title":"iScience"},{"key":"R18-20250603","first-page":"2","article-title":"Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"103","author":"Lipsky","year":"2012","journal-title":"J Am Podiatr Med Assoc"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41419-021-03969-1","article-title":"A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-7-10","article-title":"Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia","volume":"7","author":"Muller","year":"2007","journal-title":"BMC Infect Dis"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ajpath.2011.03.013","article-title":"Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis","volume":"179","author":"Narasaraju","year":"2011","journal-title":"Am J Pathol"},{"key":"R22-20250603","first-page":"1070","article-title":"Novel biomarkers differentiating viral from bacterial infection in febrile children: future perspectives for management in clinical praxis","volume":"8","author":"Rhedin","year":"2021","journal-title":"Children (Basel)"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"10243","DOI":"10.3390\/ijms221910243","article-title":"Recent strategies to combat infections from biofilm-forming bacteria on orthopaedic implants","volume":"22","author":"Rodriguez-Merchan","year":"2021","journal-title":"Int J Mol Sci."},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jinf.2019.02.006","article-title":"The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: a systematic review and meta-analysis","volume":"78","author":"Russell","year":"2019","journal-title":"J Infect"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1741-7015-9-107","article-title":"Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future","volume":"9","author":"Schuetz","year":"2011","journal-title":"BMC Med"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.aan6828","article-title":"Single-cell transcriptomics to explore the immune system in health and disease","volume":"358","author":"Stubbington","year":"2017","journal-title":"Science."},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00264-017-3412-7","article-title":"Diagnosis of periprosthetic joint infection using alpha-defensin test or multiplex-PCR: ideal diagnostic test still not found","volume":"1","author":"Suda","year":"2017","journal-title":"Int Orthop"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3389\/fimmu.2019.02948","article-title":"Transcriptional profiling of human peripheral blood mononuclear cells identifies diagnostic biomarkers that distinguish active and latent tuberculosis","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13238-014-0109-1","article-title":"Characterization of a novel mouse model with genetic deletion of CD177","volume":"6","author":"Xie","year":"2015","journal-title":"Protein Cell"},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2009.07.006","article-title":"Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans","volume":"6","author":"Zaas","year":"2009","journal-title":"Cell Host Microbe"},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"631308","DOI":"10.3389\/fimmu.2021.631308","article-title":"Future biomarkers for infection and inflammation in febrile children","volume":"12","author":"Zandstra","year":"2021","journal-title":"Front Immunol"},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"110996","DOI":"10.1016\/j.biopha.2020.110996","article-title":"Inhibiting RRM2 to enhance the anticancer activity of chemotherapy","volume":"133","author":"Zhan","year":"2021","journal-title":"Biomed Pharmacother"}],"container-title":["Clinical Orthopaedics &amp; Related Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CORR.0000000000003402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:20:04Z","timestamp":1748982004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CORR.0000000000003402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/corr.0000000000003402","relation":{},"ISSN":["0009-921X","1528-1132"],"issn-type":[{"value":"0009-921X","type":"print"},{"value":"1528-1132","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"2024-08-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}